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Adipocyte factors play a major role in the induction of
insulin resistance in skeletal muscle. To analyze this
cross-talk, we established a system of co-culture of
human fat and skeletal muscle cells. Cells of three
muscle donors were kept in co-culture with cells of
various fat cell donors, and insulin signaling was subse-
quently analyzed in myocytes. Insulin-induced tyrosine
phosphorylation of insulin receptor substrate (IRS)-1
was completely blocked, with unaltered expression of
IRS-1. Troglitazone increased insulin action on IRS-1
phosphorylation, in both the absence and presence of
co-culture. Insulin-regulated activation of Akt kinase in
the myocytes was signiﬁcantly reduced after co-culture,
with troglitazone restoring insulin action. Addition of
tumor necrosis factor (TNF)- (2.5 nmol/l) to myocytes
for 48 h reduced IRS-1 expression and inhibited IRS-1
and Akt phosphorylation comparable to the effect of
co-culture. Lower doses of TNF- were ineffective. Af-
ter co-culture, TNF- in the culture medium was below
the detection limit of 0.3 pmol/l. A very low level of
resistin was detected in the supernatant of myocytes,
but not of adipocytes. In conclusion, the release of fat
cell factors induces insulin resistance in human skeletal
muscle cells; however, TNF- and resistin appear not to
be involved in this process. Diabetes 51:2369–2376,
2002
O
besity is almost invariably associated with in-
sulin resistance and represents one of the ma-
jor risk factors for the development of type 2
diabetes. It is now believed that a negative
cross-talk between excess body fat and skeletal muscle
disturbs insulin signaling in muscle and ﬁnally generates
muscle insulin resistance, representing a key feature of
type 2 diabetes that is observed early in the prediabetic
state (1,2). Recent studies have shown that adipose tissue
can be regarded as a major secretory and endocrine organ,
and a variety of factors released by adipose cells poten-
tially mediate skeletal muscle insulin resistance (3,4).
These factors include free fatty acids, tumor necrosis
factor (TNF)-, angiotensinogen, interleukin-6, and the
recently discovered hormone resistin. However, the pre-
cise role of these factors for human insulin resistance has
remained elusive.
Substantial evidence supports a key role for TNF- in
the insulin resistance of obesity, at least in rodents (5).
Thus, overexpression of TNF- from adipose tissue was
commonly observed in different rodent models of obesity
(6,7), and direct exposure of isolated cells to TNF-
inhibits insulin signaling and induces a state of insulin
resistance (8–10). In contrast to rodents, however, TNF-
is expressed at much lower levels in human adipose tissue
(11), and antibody-mediated neutralization of TNF- com-
pletely failed to improve insulin sensitivity in obese hu-
mans (12). Recent studies in murine models suggest that a
novel adipocyte peptide hormone, resistin, may represent
the link between obesity and insulin resistance (13). Again,
recent data by Savage et al. (14) show that this hypothesis
may not readily translate to humans, since human resistin
was found to be predominantly expressed in mononuclear
cells and was low or even absent in adipocytes. In light of
these considerations, additional work using primary hu-
man cells is needed to characterize the cross-talk between
human fat and muscle cells. Furthermore, a recent study
by Goodpaster et al. (15) using cross-sectional computed
tomography imaging has shown that adipose tissue dis-
persed within muscle strongly correlated to insulin resis-
tance. Thus, a paracrine interaction of fat and muscle cells
may represent a key step in the development of muscle
insulin resistance.
In an attempt to study these processes under more
physiological conditions, we have established a novel
system of co-culture of differentiated human adipocytes
and human skeletal muscle cells. Using this model, we
addressed the following: 1) whether co-culture disturbs
insulin signaling in skeletal muscle cells and whether this
can be prevented by thiazolidinediones, 2) whether the
effect of co-culture can be mimicked by TNF-, and 3)
whether TNF- and resistin are released under co-culture
conditions. Our data show that adipocytes induce a pro-
found paracrine perturbation of insulin signaling in skele-
tal muscle cells. However, neither TNF- nor resistin is
involved in this process.
RESEARCH DESIGN AND METHODS
Reagents. Reagents for SDS-PAGE were supplied by Amersham Pharmacia
Biotech (Braunschweig, Germany) and by Sigma (Mu ¨nchen, Germany). BSA
(fraction V, fatty acid free) was obtained from Boehringer (Mannheim,
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ECL, enhanced chemiluminescence; ELISA, enzyme-linked immunosorbent
assay; HRP, horseradish peroxidase; IRS, insulin receptor substrate; PI,
phosphatidylinositol; PPAR-, peroxisome proliferator–activated receptor-;
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DIABETES, VOL. 51, AUGUST 2002 2369Germany), protein A trisacryl beads were from Pierce (Rockford, IL), and
human recombinant TNF- was from Sigma. Polyclonal anti–IRS-1 antiserum
was a gift from Dr. J.A. Maassen (Leiden, the Netherlands). Polyclonal
antibodies anti–phospho-Akt (Ser473) and anti-Akt were supplied by Cell
Signaling Technology (Frankfurt, Germany). The anti-phosphotyrosine anti-
body (RC-20) coupled to horseradish peroxidase (HRP) was from Transduc-
tion Laboratories (Lexington, KY). HRP-conjugated goat anti-rabbit IgG
antibody was from Promega (Mannheim, Germany). Collagenase CLS type 1
was obtained from Worthington (Freehold, NJ), and culture media were
obtained from Gibco (Berlin, Germany). Primary human skeletal muscle cells
and supplement pack for growth medium were obtained from PromoCell
(Heidelberg, Germany). Sterile plasticware for tissue culture was purchased
from Falcon (Becton Dickinson, Heidelberg, Germany). Membrane inserts for
six-well culture dishes with a pore size of 0.4 m (pore density 1.6  10
6 per
cm
2) and insert companion plates were supplied by Falcon. All other
chemicals were of the highest analytical grade commercially available and
were purchased from Sigma.
Culture of human skeletal muscle cells. Satellite cells were isolated from
M. rectus abdominis by enzymatic digestion with trypsin followed by a
puriﬁcation step with ﬁbroblast-speciﬁc magnetic beads to prevent contami-
nation with ﬁbroblasts. After two passages, the myoblasts are characterized
by the manufacturer (PromoCell) using immunohistochemical detection of
sarcomeric myosin in differentiated cultures at 100% conﬂuence (8 days).
Primary human skeletal muscle cells of three healthy Caucasian donors (male,
9 and 28 years of age [M9, M28] and female, 10 years old [F10]) were supplied
as proliferating myoblasts (5  10
5 cells). For all donors, chronic diseases,
including diabetes and a family history of diabetes, were excluded. These cells
were grown to conﬂuence in 25-cm
2 ﬂasks, trypsinized, and subsequently
seeded in 175-cm
2 ﬂasks at a density of 1  10
6 cells. After two passages,
5–7.5  10
7 cells were harvested and stored until further use as frozen
aliquots containing 2  10
6 myoblasts. For an individual experiment, myo-
blasts were then seeded in six-well culture dishes (9.6 cm
2/well) at a density
of 10
5 cells per well and cultured in -modiﬁed Eagle’s/Ham’s F-12 medium
containing Skeletal Muscle Cell Growth Medium Supplement Pack (Promo-
Cell) to near conﬂuence. The cells were then differentiated and fused by
culture in -modiﬁed Eagle’s medium supplemented with 2% FCS for 7 days.
The myocytes were cultured in differentiation medium without FCS for 24 h
before being used for any experiment.
Adipocyte isolation and culture. Adipose tissue samples were obtained
from the mammary fat of 12 normal-weight or moderately overweight women
(BMI 22–29.4 kg/m
2, between 29 and 50 years of age) undergoing surgical
mammary reduction. All subjects were healthy and had no evidence of
diabetes according to routine laboratory tests. Adipose tissue samples were
dissected from other tissues and minced in pieces of 10 mg. Preadipocytes
were isolated by collagenase digestion as previously described (16). Isolated
cell pellets were resuspended in Dulbecco’s modiﬁed Eagle’s/Ham’s F12
medium supplemented with 10% FCS, seeded on membrane inserts (3.5 
10
5/4.3 cm
2) in a six-well culture dish, and kept in culture for 16 h. After
washing, culture was continued in an adipocyte differentiation medium, as
detailed previously (16). After a period of 15 days, 60–80% of seeded
preadipocytes developed to differentiated adipose cells, as deﬁned by cyto-
plasma completely ﬁlled with small or large lipid droplets. This population of
cells, subsequently designated as differentiated adipocytes, was used for the
co-culture experiments. Preliminary data in our laboratory have shown a
similar hormonal control of adipose differentiation in preadipose cells from
mammary adipose tissue and the subcutaneous abdominal depot. Further-
more, the release of leptin and plasminogen activator inhibitor 1 (PAI-1) was
found to be comparable from the two depots.
Co-culture. After in vitro differentiation of preadipocytes on membrane
inserts, the adipocytes were washed once with PBS and then incubated for
24 h in skeletal muscle cell differentiation medium containing 1 pmol/l insulin.
Thereafter, adipocytes were washed twice with PBS, and individual mem-
brane inserts were subsequently transferred to the culture plates containing
differentiated (8 days) myocytes in -modiﬁed Eagle’s medium containing 1
pmol/l insulin. This resulted in an assembly of the two cell types sharing the
culture medium but separated by the membrane of the insert. Distance from
the bottom of the culture dish to the membrane was 0.9 mm. Co-culture was
conducted for 48 h. Integrity of the two cell types was routinely checked by
light microscopy at the end of the co-culture period.
Immunoprecipitation. Muscle cells were treated as indicated and lysed in a
buffer containing 50 mmol/l Tris/HCl (pH 7.4), 1% (vol/vol) NP-40, 0.25%
(vol/vol) sodium-deoxycholate, 150 mmol/l NaCl, 1 mmol/l EGTA, 1 mmol/l
Na3VO4, and protease inhibitor cocktail. After incubation for2ha t4 °C, the
suspension was centrifuged at 10,000g for 10 min. Thereafter the supernatant
(0.3 mg protein) was used for immunoprecipitation. Anti–IRS-1 antiserum (5
l) was preadsorbed to 20 l protein A trisacryl beads, which were then added
to the solubilized cell supernatant and incubated overnight at 4°C with gentle
rotation. The immunopellet was collected by centrifugation and washed three
times with ice-cold Tris-buffered saline (TBS). The pellet was incubated for 10
min at 95°C with 20 l electrophoresis buffer and centrifuged, and the
complete supernatant was used for Western blot analysis.
Immunoblotting. Immunoprecipitates or total cell lysates were separated by
SDS-PAGE using gradient (8–18%) horizontal gels and transferred to polyvi-
nylidene diﬂuoride ﬁlters in a semidry blotting apparatus (17). For phospho-
tyrosine detection, ﬁlters were blocked for 60 min in TBS containing 0.05%
Tween-20 and 1% BSA. Thereafter, ﬁlters were incubated overnight with a
1:10,000 dilution of the anti-phosphotyrosine antibody (RC-20) coupled to
HRP and subsequently processed for enhanced chemiluminescence (ECL)
detection using SuperSignal Substrate (Pierce). For detection of IRS-1, p-Akt
or Akt ﬁlters were blocked with TBS containing 0.05% Tween-20 and 5% nonfat
dry milk and incubated overnight with a 1:1,000 dilution of appropriate
antibody. After extensive washing, ﬁlters were incubated with goat anti-rabbit
HRP-coupled antibody and processed for ECL detection. Signals were visual-
ized and evaluated on a LUMI Imager workstation using image analysis
software (Boehringer Mannheim).
ELISA for TNF- and resistin. TNF- and resistin secreted by adipocytes
and human skeletal muscle cells into the culture medium were quantiﬁed
using ELISA kits from either Research Diagnostics or Phoenix Pharmaceuti-
cals (Belmont, CA). Differentiated adipocytes and skeletal muscle cells were
incubated for 48 h either individually or under co-culture conditions using the
culture medium outlined above. After that time, the cell culture supernatants
were collected and concentrated using Vivaspin Columns (Sartorius, Go ¨ttin-
gen, Germany). The assay was then performed as recommended by the
manufacturer using duplicate samples for all determinations. Sensitivity of the
assay procedure was ensured by addition of known amounts of TNF- or
resistin.
Presentation of data and statistics. All data analysis was performed using
Prism (GraphPad, San Diego, CA) or t-ease (ISI, Philadelphia) statistical
software. Signiﬁcance of reported differences was evaluated using the null
hypothesis and t statistics for paired data. A P value 0.05 was considered
statistically signiﬁcant.
RESULTS
Insulin signaling in human skeletal muscle cells after
co-culture with adipocytes. Human skeletal muscle cells
in primary culture have been shown to represent a valu-
able tool for studies of insulin action in this tissue (18–20).
We have now co-cultured these cells with differentiated
human adipocytes to investigate the cross-talk between
the tissues. Initial experiments indicated that the two cell
types can be kept in the same medium and can be
co-cultured for at least 48 h without any gross morpholog-
ical alterations. Using this protocol, cells of three skeletal
muscle donors were co-cultured with adipocytes of three
to ﬁve different fat cell donors; after removal of the fat
cells, the myocytes were acutely stimulated with insulin.
As presented in Fig. 1A, a strong increase in insulin-
stimulated tyrosine phosphorylation of IRS-1 was ob-
served under control conditions.
After co-culture, this insulin response was largely re-
duced in skeletal muscle cells from donors M9 and F10. In
cells from donor M28, a reproducible increase in the basal
tyrosine phosphorylation of IRS-1 occurred after co-cul-
ture, with no additional effect of insulin (Fig. 1A). Quanti-
ﬁcation of the data for the three individuals indicated that
insulin was unable to produce a signiﬁcant stimulation of
tyrosine phosphorylation of IRS-1 in skeletal muscle cells
subjected to co-culture with adipocytes (Fig. 1B). It should
be noted that the level of IRS-1 expression in the myocytes
was not affected by the co-culture (see Fig. 3B).
We next assessed the effect of the thiazolidinedione
compound troglitazone on the induction of insulin resis-
tance in the co-culture system. When added for 48 h in the
absence of adipocytes, troglitazone sensitized the skeletal
muscle cells toward insulin, with a twofold increase in the
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IRS-1 (Fig. 1A and B), without affecting IRS-1 expression.
Addition of troglitazone to the co-culture 1) completely
prevented the perturbation of insulin signaling at the level
of IRS-1 (Fig. 1A) and 2) sensitized the skeletal muscle
cells toward insulin to the same degree as in the absence
of adipocytes (Fig. 1B).
As presented in Fig. 2, the co-culture conditions were
also found to induce prominent insulin resistance in the
skeletal muscle cells at the level of the serine/threonine
kinase Akt, a central component of downstream insulin
signaling to glucose transport and glycogen synthesis (21).
Under control conditions, insulin produced a three- to
fourfold increase in the Ser473 phosphorylation of Akt in
the myocytes, with a signiﬁcant (P  0.001) reduction of
this response (by 60–70%) after co-culture with adipocytes
(Fig. 2A and B). It is worth noting that in cells from donor
F10, we observed a reproducible increase in the basal
serine phosphorylation of Akt, with no additional effect
of insulin (Fig. 2A). As found for IRS-1, the expression of
Akt was not affected by the co-culture conditions. Trogli-
tazone strongly sensitized the skeletal muscle cells toward
insulin-mediated activation of Akt, with a parallel 1.5- to
2-fold increase in the protein expression of this enzyme
(Fig. 2). The sensitizing effect of troglitazone was not
observed under co-culture conditions; however, the thiazo-
lidinedione compound restored a completely normal insu-
lin response of Akt serine phosphorylation in the skeletal
muscle cells (Fig. 2).
Effect of TNF- on insulin signaling in human skele-
tal muscle cells. The role of TNF- in the development of
insulin resistance under co-culture conditions was as-
sessed by culturing human skeletal muscle cells for 48 h in
the presence of a high dose of the cytokine. Direct addition
FIG. 1. Muscle cells were incubated for 48 h in co-culture with adipocytes, as detailed in RESEARCH DESIGN AND METHODS. Fat cells were then removed,
and the myocytes were stimulated with 100 nmol/l insulin (10 min) followed by cell lysis and immunoprecipitation of IRS-1. A: IRS-1
immunoprecipitates were resolved by SDS-PAGE and immunoblotted with anti-phosphotyrosine and anti–IRS-1 antisera. Signals were visualized
using ECL detection. Representative blots for the three muscle cell donors are shown. B: Western blots were quantiﬁed on a LUMI Imager
workstation using image analysis software. Results were corrected for the actual amount of IRS-1 present in the immunoprecipitates and are
expressed relative to the insulin-stimulated control, which was set as 100. Data are means  SE of 10–12 experiments from three different muscle
cell donors (M9, n  3; F10, n  4; M28, n  3–5). *Signiﬁcantly different from insulin-stimulated control, P < 0.05.
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the protein expression of IRS-1 by 40% (Fig. 3A), with
troglitazone preventing this reduction. In contrast, unal-
tered IRS-1 expression was observed in myocytes sub-
jected to co-culture (Fig. 3B).
Akt protein expression remained unaffected by TNF-.
As presented in Fig. 4, insulin signaling to both IRS-1 and
Akt was completely blocked in skeletal muscle cells
cultured in the presence of 2.5 nmol/l TNF-. Troglitazone
ameliorated this insulin resistance, in agreement with our
ﬁndings in skeletal muscle cells subjected to co-culture
with adipocytes. It should be noted that all data on protein
phosphorylation were corrected for the actual amount of
IRS-1 and Akt present in the immunoprecipitates and
lysates, respectively.
The data obtained so far indicated that TNF- was able
to mimic the effect of co-culture on insulin signaling in
human skeletal muscle cells. It was therefore of interest to
study this effect of TNF- using lower, physiologically
more relevant doses. The dose-response relationship for
IRS-1 and Akt expression and phosphorylation is pre-
sented in Fig. 5A and B.
As can be seen from the data, insulin signaling to IRS-1
remained unaffected at 0.15 and 1 nmol/l TNF-, with a
dose-dependent reduction of IRS-1 expression. Insulin-
induced signaling to Akt was also reduced in a dose-
dependent fashion by TNF-; however, even at 1 nmol/l of
the cytokine, this reduction was not more than 30% (Fig.
5B). Only at 2.5 nmol/l TNF- was the perturbation of
insulin signaling in the skeletal muscle cells comparable to
the results obtained in the co-culture of myocytes and
adipocytes.
Secretion of TNF- and resistin by skeletal muscle
cells and adipocytes. The dose-response data described
above make it unlikely that TNF- represents a major
mediator of insulin resistance in the co-culture system. To
further address this issue, attempts were made to quantify
the TNF- concentration in the cell culture supernatant of
skeletal muscle cells, adipocytes, and the cells in co-
culture using a highly sensitive TNF- ELISA assay (de-
FIG. 2. A: Human skeletal muscle cells were subjected to co-culture and acutely stimulated with insulin (100 nmol/l, 10 min), as described in Fig.
1. Total cell lysates (19–20 mg/lane) were resolved by SDS-PAGE and immunoblotted with phosphospeciﬁc Akt antibody and Akt antibody. Each
donor is represented by typical blot. B: Quantiﬁcation of immunoblots was performed as described in Fig. 1. All data were normalized to Akt
protein expression and are expressed relative to the insulin-stimulated control value. Data are mean values  SE of seven independent
experiments from two different muscle cell donors (M9, n  3; F10, n  3–4). *Signiﬁcantly different from all other insulin-stimulated values, P <
0.05; #not signiﬁcantly different from control, P > 0.05.
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collected and concentrated 10-fold. Essentially no TNF-
was detected under these conditions after 48 h culture.
When 0.3 pmol/l of TNF- was added to the culture
medium, this amount of the cytokine was reproducibly
detected, thus validating the sensitivity of the assay.
The same analysis was subsequently performed for the
recently detected hormone resistin. This peptide has been
implicated as an adipocytokine leading to insulin resis-
tance (13). We used a resistin ELISA with a detection limit
of 5 pg/ml. As shown in Fig. 6, skeletal muscle cells were
found to secrete a measurable amount of resistin (10–20
pg/ml) into the culture medium, whereas the hormone
remained below the detection level in the supernatant of
the differentiated adipocytes. Under co-culture conditions
and in the presence of troglitazone, resistin was also
detected in the culture medium, with a trend for even
lower values compared with skeletal muscle cells alone
(Fig. 6).
DISCUSSION
Skeletal muscle accounts for 80% of total glucose dis-
posal under insulin-stimulated conditions (22), and defects
of insulin action in this tissue are central to the pathogen-
esis of type 2 diabetes. Based on animal studies, it has
been postulated that the overproduction of TNF- and
resistin by adipose tissue may link obesity to type 2
diabetes (5,13). However, it remains questionable if this
concept may be translated to humans (12,14). Further-
more, adipose tissue is also dispersed within muscle (15).
This intramuscular fat increases with obesity (23), which
may lead to a paracrine interaction between adipose and
muscle cells potentially involving much lower concentra-
tions of adipocyte factors. We report here for the ﬁrst time
on the co-culture of human adipocytes and human skeletal
muscle cells, a generally accepted approach for studies on
the paracrine interaction between two cell types (24,25).
Our results support the notion of a signiﬁcant cross-talk
between fat and muscle cells but exclude the involvement
of TNF- and resistin in this process.
A key ﬁnding of the present investigation is the obser-
vation of a profound disturbance of insulin signaling in
muscle cells subjected to co-culture. This involves the
absence of insulin-stimulated phosphorylation of IRS-1
and the reduced ability of the hormone to stimulate
Akt-kinase, without affecting the expression of these pro-
teins. Recent studies on insulin signaling in human skeletal
muscle of obese type 2 diabetic patients have shown that
insulin was completely unable to stimulate the phosphati-
dylinositol (PI) 3-kinase pathway in muscle biopsies of
these subjects, as measured by the absence of both
insulin-regulated phosphorylation of IRS-1 and activation
of PI 3-kinase (26,27). These data are in excellent agree-
ment with the present results obtained in the co-culture
system and deﬁne the IRS-1/PI 3-kinase pathway as a key
step in the development of insulin resistance. An apparent
difference between adolescent and adult muscle donors
was observed, concerning the potential mechanism under-
lying the absence of insulin-stimulated phosphorylation of
IRS-1 (see Fig. 1). However, several lines of evidence
support the view that this difference more likely reﬂects an
inter-individual variation in the sensitivity of the myotubes
FIG. 3. A: Muscle cells were incubated for 48 h in the absence or presence of 2.5 nmol/l TNF- without or with 5 mmol/l troglitazone. After 24-h
incubation, the medium was completely removed and replaced by fresh differentiation medium supplemented with TNF- and troglitazone, as
indicated. Cells were lysed, and total cell lysates were resolved by SDS-PAGE and immunoblotted with anti–IRS-1 antiserum. Results are
expressed relative to the control value (deﬁned as 100). Data are means  SE of 13 independent experiments from three different muscle cell
donors (M9, n  3–5; F10, n  3–5; M28, n  3). Representative blots are shown. *Signiﬁcantly different from control, P < 0.005. B: Muscle cells
were subjected to co-culture as described in Fig. 1. Total cell lysates were resolved by SDS-PAGE and immunoblotted with anti–IRS-1 antiserum.
Quantiﬁcation was performed as in A. Data are means  SE of 12 independent experiments from three different muscle cell donors.
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contrast to rodent models, the proliferative capacity and
the program of myogenic differentiation were found to be
identical in 9-year-old and 60-year-old humans (28,29).
Second, we have determined the differentiation-dependent
gene expression proﬁle (including insulin receptor, IRS-1,
and IRS-2) of myoblasts from the three donors and did not
detect any difference (J.E. and T. Gromke, unpublished
data). Third, a consistent response toward TNF- was
observed for the three individuals (Figs. 3 and 4). At the
present stage, the precise mechanism leading to the abro-
gation of insulin-stimulated tyrosine phosphorylation of
IRS-1 after co-culture remains unknown.
Using in vitro incubations of skeletal muscle strips from
type 2 diabetic patients, Krook et al. (30) reported a
marked reduction in insulin-stimulated Akt kinase at high
concentrations of the hormone. In subsequent studies
using in vivo insulin stimulation, however, the phosphor-
ylation and activation of the three Akt isoforms was found
to be normal in skeletal muscle from obese type 2 diabetic
subjects (31), and the role of Akt for human insulin
resistance has been questioned. In contrast, our data
suggest that the negative cross-talk between fat and mus-
cle may largely abrogate insulin-regulated activation of
Akt. Some limitations of our in vitro system may explain
these discrepancies. Thus, 1) desensitization of Akt may
be transient and reversible, 2) ﬁber type–speciﬁc insulin
signaling (32) must be considered, and 3) only a subset of
skeletal muscle tissue is subject to the paracrine interac-
tion in vivo, making potential alterations undetectable in a
large muscle sample. Interestingly, in a recent study,
Storgaard et al. (33) reported a tendency for reduced
activation of Akt in skeletal muscle of ﬁrst-degree relatives
of type 2 diabetic patients after in vivo insulin stimulation.
Additional work will be needed to clarify the role of Akt in
skeletal muscle insulin resistance.
The thiazolidinedione compound troglitazone com-
pletely prevented the insulin resistance in skeletal muscle
cells when present during the co-culture with adipocytes.
This observation excludes nonspeciﬁc alterations of the
myocytes and shows that our co-culture approach should
be useful for deﬁning novel pharmacological interventions
of the cross-talk between fat and muscle. It is generally
assumed that troglitazone acts primarily on adipocytes by
binding to the nuclear peroxisome proliferator–activated
receptor- (PPAR-) and that the improvement of insulin
responsiveness in skeletal muscle of type 2 diabetic pa-
tients is indirect (34). This may result from a decrease in
elevated free fatty acid levels and a change in the body
distribution pattern of adipose tissue (35). As reported by
Park et al. (36), PPAR- is also present in primary cultured
human skeletal muscle cells, with increased expression
upon culture with troglitazone. We have conﬁrmed this
increased expression of PPAR- in our cultures of human
skeletal muscle cells (data not shown) and show here a
prominent sensitization of insulin signaling in skeletal
muscle cells exposed to troglitazone. Our data do not
exclude effects of troglitazone on the release of adipocyte
factors; nevertheless, it is evident that the direct effect on
human skeletal muscle cells is sufﬁcient to prevent the
insulin resistance induced by the cross-talk with adipo-
cytes.
When added at high concentrations, TNF- was able to
mimic the disturbance of insulin signaling found after
co-culture; however, concentrations 1,000 pmol/l were
marginally effective. This result differs markedly from our
earlier study on human adipocytes, where we reported
that TNF- at 10 pmol/l was able to attenuate insulin
signaling (10). Thus, auto-/paracrine effects of TNF- on
adipocytes may be much more relevant for the induction
of insulin resistance in adipose tissue than the effects of
the cytokine on skeletal muscle. This notion is strongly
supported by a recent study on human skeletal muscle
cells showing no effect of 300 pmol/l TNF- on insulin-
mediated activation of Akt kinase (19). Importantly, we
were unable to detect TNF- in the co-culture medium
despite using a highly sensitive assay with a detection limit
of 0.2 pmol/l. Taking into account that the culture medium
was concentrated 10-fold, the TNF- level during the
co-culture can be estimated to be 0.02 pmol/l. These
considerations strongly suggest that TNF- is not respon-
sible for the insulin resistance observed in skeletal muscle
FIG. 4. A: Cells were cultured for 48 h with TNF- and troglitazone, as
detailed in Fig. 3. After stimulation with insulin (100 nmol/l for 10
min), IRS-1 was immunoprecipitated, and the tyrosine phosphorylation
of IRS-1 was determined and quantiﬁed as described in Fig. 1. The inset
shows a representative Western blot. Data are means  SE of 15
independent experiments using skeletal muscle cells of the three
different donors. Data are expressed relative to the insulin-stimulated
control. B: Cells were cultured as outlined for A, and total cell lysates
were used for the analysis of insulin-induced serine phosphorylation of
Akt, as detailed in Fig. 2. The inset shows a representative Western
blot. Data represent means  SE of 10 independent experiments using
skeletal muscle cells of the three different donors. All data were
normalized to the level of Akt expression and are expressed relative to
the insulin-stimulated control.
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suggestion, no correlation between insulin sensitivity and
subcutaneous adipose tissue TNF- expression could be
detected in obese type 2 diabetic patients (37). Further-
more, TNF- is expressed at much lower levels in human
adipose tissue compared with rodents (11). However, it
cannot be ruled out that TNF- induces muscle insulin
resistance in a synergistic fashion together with other yet
unidentiﬁed adipocyte factors.
The peptide resistin represents such a recently detected
novel adipocyte factor, and based on rodent studies, it has
been postulated that resistin acts as a hormonal link
between obesity and insulin resistance (13). We show here
that resistin is undetectable in the supernatant of differ-
entiated mammary human adipocytes and therefore con-
clude that resistin does not mediate the negative cross-talk
between fat and muscle in our co-culture system. Our
ﬁndings agree with two recent reports showing low/absent
expression of resistin in human adipocytes, with a high
interindividual variability and no correlation to BMI
(14,38). Instead, resistin was found to be predominantly
expressed in mononuclear cells (14). Interestingly, resistin
appears to be secreted by untreated skeletal muscle cells,
with a tendency to a reduction in the co-culture. This
clearly rules out resistin as a mediator of insulin resistance
in human skeletal muscle. In addition to cytokines, free
fatty acids may also be involved in the negative cross-talk
between fat and muscle (39). However, studies by Kausch
et al. (40) suggest that palmitate, 2-bromo-palmitate, and
linoleate do not modify insulin signaling in primary cul-
tured human skeletal muscle cells. Initial experiments in
our laboratory conﬁrm these ﬁndings and make it unlikely
that the results obtained in the co-culture can be explained
by the release of free fatty acids.
In summary, we describe here the co-culture of human
skeletal muscle cells and human adipocytes as a novel
model system for studies on the paracrine interaction
between fat and muscle. Our data show that adipocytes
FIG. 5. A: Myocytes were cultured with TNF- for 48 h using the indicated concentrations of the cytokine. Cell lysates were then analyzed by
immunoblotting using antisera for IRS-1 and Akt. Results are expressed relative to the untreated control value and represent means  SE of 10
independent experiments using cells of donor M9 and F10. Signiﬁcantly different from control, *P < 0.05; #P < 0.005. B: Cells were cultured as
in A, and the insulin-induced tyrosine phosphorylation of IRS-1 and the serine phosphorylation of Akt were determined by Western blotting and
quantiﬁed as described in Figs. 1 and 2. Data are means  SE of 10 independent experiments. *Signiﬁcantly different from control, P < 0.05.
FIG. 6. Culture media from skeletal muscle cells (SkMc), adipocytes,
troglitazone (Tro)-treated skeletal muscle cells, and co-culture were
collected and concentrated 10-fold, and resistin was determined using
a resistin ELISA kit. Data are means  SE (n  8) using skeletal
muscle cells of donor M9 and F10. There are no statistically signiﬁcant
differences. The y-axis starts at detection limit.
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DIABETES, VOL. 51, AUGUST 2002 2375induce a rapid disturbance of insulin signaling in skeletal
muscle cells that is not mediated by TNF- and resistin. It
is suggested that a complex array of adipocyte factors is
responsible for generating muscle insulin resistance.
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